4.120USD-2.60%Mkt Cap: 516.85M USDP/E: —Last update: 2026-05-22
Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a su…
Industry Peers
Drug Manufacturers - Specialty & Generic153.28BSEKP/E 169.8
56.23BTRYP/E 26.9
55.91BEURP/E 22.1
33.39BPLNP/E 21.7
13.24BSEKP/E 39.8
13.20BEURP/E 30.1
12.83BTRY—
10.85BUSD—
loading…
Indicators:|
Key Statistics
Company
Market Cap516.85M USD
Enterprise Value463.50M USD
Revenue (TTM)50.27M USD
Gross Profit25.99M USD
Net Income (TTM)-83.78M USD
Revenue/Share0.4420 USD
Last Price4.120 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees147
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.40
PEG—
EV/EBITDA-8.38
EV/Revenue9.22
P/S10.56
P/B-15.44
EPS (TTM)-0.61
EPS (Forward)-0.45
52W Range
2.22236% of range7.550
52W High7.550 USD
52W Low2.222 USD
Profitability
Gross Margin58.35%
Oper. Margin-29.10%
EBITDA Margin-110.09%
Profit Margin-188.09%
ROE248.90%
ROA-52.23%
Growth
Revenue Growth65.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-52.43M USD
CapEx (TTM)562.00K USD
FCF Margin-51.10%
FCF Yield-4.97%
Net Debt-67.15M USD
Net Debt/EBITDA1.21
Balance Sheet
Debt/Equity-1.26
Current Ratio4.10
Quick Ratio3.70
Book Value/Sh-0.2740 USD
Cash/Share0.8830 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)8.889 USD
Target Range6.000 USD – 11.00 USD
# Analysts9
Ownership
Shares Out.125.45M
Float114.68M
Insiders3.10%
Institutions60.66%
Short Interest
Short Ratio13.1d
Short % Float13.06%
Short % Out.12.47%
Shares Short15.50M
Short (prev mo.)17.56M
Technical
SMA 504.152 (-0.8%)
SMA 2004.874 (-15.5%)
Beta1.50
S&P 52W Chg28.31%
Avg Vol (30d)1.56M
Avg Vol (10d)2.32M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—